Syensqo invests in green chemistry start-up Bioeutectics

By Isabel Cameron

- Last updated on GMT

© Syensqo
© Syensqo

Related tags Chemistry Solvent start-ups Active ingredient

Green chemistry start-up Bioeutectics has bagged $2.1 million in venture capital funding to develop its green solvent technology.

The round was led by Syensqo, with participation from Fen Ventures, Atento Capital and SOSV (IndieBio). 

Founded in 2019, Bioeutectics provides natural and high-performance solvents that make industrial products and processes more sustainable.

“We are excited to have Syensqo onboard to help us bring these early-stage innovations to the market. Syensqo’s expertise in solvents and formulation is key to our success,” said Tomas Silicaro, CEO of Bioeutectics.

Based on natural deep eutectic solvents (NADES) technology, Bioeutetics mimics the way plants elaborate their own solvents, using renewable sources.

By replacing petrochemical-based solvents with natural alternatives, the company offers solvents with an improved environmental, health, and safety profile.

According to both companies, this new investment also strengthens the existing partnership between Syensqo Ventures and the Genesis Consortium, supporting startups in the SOSV’s IndieBio startup development program.

“We see a growing demand for efficient and environmentally friendly solvents, which can also be biodegradable, non-toxic and affordable. Bioeutetics’ cutting-edge technology is at the forefront of solvent innovation, combining high-performance, quality and sustainability that could bring real added value to Syensqo’s portfolio of products,” said Jean-Christophe Castaing, global R&I director, new technologies at Syensqo.

Syensqo Ventures partner Coppelia Marincovic also said he was ‘thrilled’ to partner with the sustainable start-up, who is working on the future of green solvents.

“Bioeutectics has developed not only specific products but also a platform to design these innovative solvents, increasing significantly the potential applications,'' he added.

Related news

Follow us

Webinars